Avalon GloboCare grants 400,000 options to interim CEO

Avalon GloboCare Corp. reported an equity compensation grant to Interim CEO Li Meng.

Accepted by SEC EDGAR 07/13/2026 - 04:31 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Avalon GloboCare Corp. reported an equity compensation grant to Interim CEO Li Meng. On June 29, 2026, Meng received options to buy 400,000 shares of common stock at an exercise price of $0.282 per share. According to the terms, 100% of these options vested immediately on the grant date and they expire on June 29, 2029. Following this award, Meng holds 402,000 derivative securities directly.

Insider Trade Summary

Grant/Award: 400,000 shares

Grant/Award 1 txn

Insider Li Meng

Role Interim CEO

Type	Security	Shares	Price	Value
Grant/Award	Options (right to buy) F1	400,000	$0.00	$0.00

Holdings After Transaction: Options (right to buy) — 402,000 contracts (Direct)

Footnotes (1)

1. F1. One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date.

Key Figures

Options Granted: 400,000 options Exercise Price: $0.282 per share Expiration Date: June 29, 2029 +2 more

5 metrics

Options Granted 400,000 options Grant of options to buy common stock on June 29, 2026

Exercise Price $0.282 per share Conversion or exercise price of the granted options

Expiration Date June 29, 2029 Expiration of the granted stock options

Total Derivative Holdings After Grant 402,000 Total derivative securities held directly by Li Meng after the transaction

Transaction Price per Option $0.0000 Awarded as compensation, not purchased in the market

Key Terms

Options (right to buy), Grant, award, or other acquisition, vest in full on the grant date, exercise price

4 terms

Options (right to buy) financial

"security_title: Options (right to buy)"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

vest in full on the grant date financial

"shares subject to the Option shall vest in full on the grant date"

exercise price financial

"conversion_or_exercise_price: 0.2820"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Avalon GloboCare (ALBT) disclose about Li Meng in this Form 4?

Avalon GloboCare disclosed that Interim CEO Li Meng received a grant of options for 400,000 shares of common stock at an exercise price of $0.282 per share, fully vested on the grant date and expiring on June 29, 2029.

How many stock options did ALBT’s Interim CEO receive and at what price?

Interim CEO Li Meng received 400,000 stock options, each with an exercise price of $0.282 per share. These options relate to the company’s common stock and represent a compensation-related grant/award acquisition.

When do Li Meng’s newly granted ALBT options vest and expire?

All of Li Meng’s newly granted options vested 100% on the grant date of June 29, 2026. The options have an expiration date of June 29, 2029, after which they can no longer be exercised.

What is Li Meng’s total derivative holdings in ALBT after this transaction?

After the grant, Li Meng holds 402,000 derivative securities linked to Avalon GloboCare common stock. This figure includes the 400,000 newly granted options reported in the Form 4 as directly owned.

Was Li Meng’s Form 4 transaction in ALBT an open-market buy or sell?

The Form 4 reports a grant/award acquisition of options, coded as “A”, not an open-market purchase or sale. The options were awarded at $0.00 transaction price with an exercise price of $0.282 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Li Meng

(Last) (First) (Middle)

C/O AVALON GLOBOCARE CORP.

4400 ROUTE 9, SUITE 3100

(Street)

FREEHOLD NEW JERSEY 07728

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Avalon GloboCare Corp. [ ALBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options (right to buy)	$0.282	06/29/2026		A		400,000		06/29/2026(1)	06/29/2029	Common Stock	400,000	$0	402,000	D

Explanation of Responses:

1. One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date.

	/s/ Meng Li	07/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)